Paper388133
pA2 and receptor differentiation: a statistical analysis of competitive antagonism.
Tallarida RJ and 2 others. Life Sci, 1979. Cited by 502 papers, by iCite.
Cite this record
ConductScience Library. pA2 and receptor differentiation: a statistical analysis of competitive antagonism. Papers, record 388133. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/388133
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Binding, Competitive | Major topic |
| Drug Antagonism | Major topic |
| Receptors, Drug | Major topic |
| Animals | |
| Drug Synergism | |
| Kinetics | |
| Pharmaceutical Preparations | |
| Statistics as Topic |
Source PubMed
Cited by75
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 502 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 28442584 | Apparent CB1 Receptor Rimonabant Affinity Estimates: Combination with THC and Synthetic Cannabinoids in the Mouse In Vivo Triad Model. | J Pharmacol Exp Ther | 2017 | https://conductscience.org/library/papers/28442584 | PubMed |
| 25356730 | Modulation of food consumption and sleep-wake cycle in mice by the neutral CB1 antagonist ABD459. | Behav Pharmacol | 2015 | https://conductscience.org/library/papers/25356730 | PubMed |
| 20002104 | Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist. | Br J Pharmacol | 2010 | https://conductscience.org/library/papers/20002104 | PubMed |
| 19641166 | Antagonism of the ethanol-like discriminative stimulus effects of ethanol, pentobarbital, and midazolam in cynomolgus monkeys reveals involvement of specific GABA(A) receptor subtypes. | J Pharmacol Exp Ther | 2009 | https://conductscience.org/library/papers/19641166 | PubMed |
| 19279568 | Behavioral effects of a synthetic agonist selective for nociceptin/orphanin FQ peptide receptors in monkeys. | Neuropsychopharmacology | 2009 | https://conductscience.org/library/papers/19279568 | PubMed |
| 18482161 | Zolpidem generalization and antagonism in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol. | Alcohol Clin Exp Res | 2008 | https://conductscience.org/library/papers/18482161 | PubMed |
| 17874317 | Comparison of naltrexone, 6alpha-naltrexol, and 6beta-naltrexol in morphine-dependent and in nondependent rhesus monkeys. | Psychopharmacology (Berl) | 2008 | https://conductscience.org/library/papers/17874317 | PubMed |
| 17079019 | Interactions between drugs and occupied receptors. | Pharmacol Ther | 2007 | https://conductscience.org/library/papers/17079019 | PubMed |
| 17075571 | In vivo pharmacological resultant analysis reveals noncompetitive interactions between opioid antagonists in the rat tail-withdrawal assay. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/17075571 | PubMed |
| 16331290 | Differential behavioral effects of low efficacy positive GABAA modulators in combination with benzodiazepines and a neuroactive steroid in rhesus monkeys. | Br J Pharmacol | 2006 | https://conductscience.org/library/papers/16331290 | PubMed |
| 16113694 | Correlation between vasoconstrictor roles and mRNA expression of alpha1-adrenoceptor subtypes in blood vessels of genetically engineered mice. | Br J Pharmacol | 2005 | https://conductscience.org/library/papers/16113694 | PubMed |
| 12839867 | Endothelin-1 inhibits TNF alpha-induced iNOS expression in 3T3-F442A adipocytes. | Br J Pharmacol | 2003 | https://conductscience.org/library/papers/12839867 | PubMed |
| 11741201 | Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand. | AAPS PharmSci | 1999 | https://conductscience.org/library/papers/11741201 | PubMed |
| 11693192 | Endocardial expression and functional characterization of endothelin-1. | Mol Cell Biochem | 2001 | https://conductscience.org/library/papers/11693192 | PubMed |
| 11682453 | alpha(1)-Adrenoceptor subtypes in the mouse mesenteric artery and abdominal aorta. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11682453 | PubMed |
| 11226131 | Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11226131 | PubMed |
| 11159715 | Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens. | Br J Pharmacol | 2001 | https://conductscience.org/library/papers/11159715 | PubMed |
| 10780961 | O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties. | Br J Pharmacol | 2000 | https://conductscience.org/library/papers/10780961 | PubMed |
| 10578124 | Contractile 5-HT1B receptors in human cerebral arteries: pharmacological characterization and localization with immunocytochemistry. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10578124 | PubMed |
| 10516656 | Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors. | Br J Pharmacol | 1999 | https://conductscience.org/library/papers/10516656 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/388133
GET https://conductscience.org/api/papers/v1/388133/cited_by?page=2